We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sleep Duration Required to Restore Performance During Chronic Sleep Restriction

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01581125
First Posted: April 19, 2012
Last Update Posted: July 18, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Elizabeth B. Klerman, Brigham and Women's Hospital
March 22, 2012
April 19, 2012
July 18, 2016
April 2012
June 2016   (Final data collection date for primary outcome measure)
Psychomotor Vigilance Task (PVT) performance [ Time Frame: PVT during waking for arms 1 and 2 during the 32-day inpatient portion of the protocol ]
PVT metrics are reaction time. It is measured when the participants are awake during the inpatient portion of the protocol.
Same as current
Complete list of historical versions of study NCT01581125 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Sleep Duration Required to Restore Performance During Chronic Sleep Restriction
Sleep Duration Required to Restore Performance During Chronic Sleep Restriction
The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase.
The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase. Inpatient sleep and performance data will be collected from healthy volunteers.
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Basic Science
  • Sleep
  • Sleep Deprivation
  • Insufficient Sleep Syndrome
  • Behavioral: Sleep:wake 1
    Sleep and Wake durations for arm 1
  • Behavioral: Sleep:wake 2
    Sleep and Wake durations for arm2
  • Experimental: Sleep:wake 2
    Sleep and wake durations for arm 2 for inpatient portion of protocol. .There are a variety of sleep and wake durations during the protocol; some of these are longer and some are shorter and some are the same as in arm 1.
    Intervention: Behavioral: Sleep:wake 2
  • Experimental: Sleep:wake 1
    Sleep and wake durations for arm 1 of the inpatient portion of the protocol. There are a variety of sleep and wake durations during the protocol; some of these are longer and some are shorter and some are the same as in arm 2.
    Intervention: Behavioral: Sleep:wake 1
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
19
June 2016
June 2016   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy

Exclusion Criteria:

  • Prescription medications
Sexes Eligible for Study: All
18 Years to 35 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01581125
NIH R01 HL114088-01
No
Not Provided
Not Provided
Elizabeth B. Klerman, Brigham and Women's Hospital
Brigham and Women's Hospital
Not Provided
Principal Investigator: Elizabeth B Klerman, MD PhD Brigham and Women's Hospital
Brigham and Women's Hospital
July 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP